As a Free StocksGuide user, you can view scores for all 7,011 stocks worldwide.
10 Analysts have issued a Prestige Brands Holdings, Inc. forecast:
10 Analysts have issued a Prestige Brands Holdings, Inc. forecast:
Jun '25 |
+/-
%
|
||
Revenue | 1,120 1,120 |
1%
1%
|
|
Gross Profit | 629 629 |
2%
2%
|
|
EBITDA | 357 357 |
2%
2%
|
EBIT (Operating Income) EBIT | 336 336 |
2%
2%
|
Net Profit | 213 213 |
4%
4%
|
In millions USD.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Prestige Consumer Healthcare, Inc. engages in the marketing, sale, and distribution of pharmaceutical drugs and consumer products. It operates through the following segments: North American OTC Healthcare, and International OTC Healthcare. The North American and International OTC Healthcare segments manages the following brands: BC/Goody's, Beano, Boudreaux's Butt Paste, Chloraseptic, Clear Eyes, Compound W, Debrox, DenTek, Dramamine, Efferdent, Fess, Fleet, Gaviscon, Hydralyte, Luden's, Monistat, Nix, Pedia-Lax, and Summer's Eve. The company was founded in 1996 and is headquartered in Tarrytown, NY.
Head office | United States |
CEO | Ronald Lombardi |
Employees | 570 |
Founded | 1996 |
Website | www.prestigebrands.com |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.